Gene expression analysis of matched ovarian primary tumors and peritoneal metastasis

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Malek, Joel A ^a,f   Martinez, Alejandra ^b   Mery, Eliane ^b   Ferron, Gwenael ^b   Huang, Ruby ^c   Raynaud, Christophe ^a   Jouve, Eva ^b   Thiery, Jean Paul ^d   Querleu, Denis ^b,e   Rafii, Arash ^a,f  

^a WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^b INSTITUT CLAUDIUS REGAUD   (France)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^e MCGILL UNIVERSITY   (Canada)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1 CYANO 1 METHYLETHYL) 3 METHYL 8 (3 QUINOLINYL)IMIDAZO[4,5 C]QUINOLIN 2(1H,3H) ONE; 4 DIALLYLAMINOMETHYLENE 1,3,4,7,10,11,12,13,14,15,16,17 DODECAHYDRO 6 HYDROXY 1 METHOXYMETHYL 10,13 DIMETHYL 3,7,17 TRIOXO 2 OXACYCLOPENTA[A]PHENANTHREN 11 YL ACETATE; [1 (4 OXO 8 PHENYL 4H 1 BENZOPYRAN 2 YL)MORPHOLINIO]METHOXYSUCCINYLARGINYLGLYCYLASPARTYLSERINE ACETATE; BUPARLISIB; CARBOPLATIN; CRIZOTINIB; DNA; INTERLEUKIN 6; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 4; PACLITAXEL; PHOSPHATIDYLINOSITOL 3 KINASE; RNA; STAT PROTEIN; TOCILIZUMAB; VEMURAFENIB; XL 147;

ADJUVANT THERAPY; ARTICLE; CLINICAL ARTICLE; COPY NUMBER VARIATION; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TARGETING; HAPLOTYPE MAP; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MULTIPLE CYCLE TREATMENT; NUCLEOTIDE SEQUENCE; OVARY CANCER; PERITONEUM METASTASIS; PERSONALIZED MEDICINE; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS;

FEMALE; GENE EXPRESSION PROFILING; HUMANS; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PROGNOSIS;

EID: 84861990353     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-121     Document Type: Article

References (19)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. Cancer Statistics, 2006. CA Cancer J Clin 2006, 56:106-130. 10.3322/canjclin.56.2.106, 16514137.
2. Cannistra S. Cancer of the ovary. N Engl J Med 2004, 351:2519-29. 10.1056/NEJMra041842, 15590954.
3. Chien J, J-bing F, Bell DA, April C, Klotzle B, et al. Gynecologic Oncology Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer. Gynecol Oncol 2009, 114:3-11. 10.1016/j.ygyno.2009.04.002, 19410283.
4. Gómez-Raposo C, Mendiola M, Barriuso J, Hardisson D, Redondo A. Molecular characterization of ovarian cancer by gene-expression profiling. Gynecol Oncol 2010, 118:88-92. 10.1016/j.ygyno.2010.03.012, 20439111.
5. Berchuck A, Iversen ES, Lancaster JM, Dressman HK, West M, et al. Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays. Am J Obstet Gynecol 2004, 190:910-25. 10.1016/j.ajog.2004.02.005, 15118612.
6. Berchuck A, Iversen ES, Lancaster JM, Pittman J, Luo J, et al. Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clinical cancer research: an official journal of the American Association for Cancer Research 2005, 11:3686-96.
7. Spentzos D, Levine DA, Ramoni MF, Joseph M, Gu X, et al. Gene expression signature with independent prognostic significance in epithelial ovarian cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004, 22:4700-10.
8. Yoshida S, Furukawa N, Haruta S, Tanase Y, Kanayama S, et al. Expression profiles of genes involved in poor prognosis of epithelial ovarian carcinoma: a review. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009, 19:992-7.
9. Lancaster JM, Dressman HK, Clarke JP, Sayer RA, Martino MA, et al. Identification of genes associated with ovarian cancer metastasis using microarray expression analysis. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006, 16:1733-45.
10. Malek JA, Mery E, Mahmoud YA, Al-Azwani EK, Roger L, et al. Copy number variation analysis of matched ovarian primary tumors and peritoneal metastasis. PLoS One 2011, 6:e28561. 10.1371/journal.pone.0028561, 3237432, 22194851.
11. Bell D, Berchuck A, Birrer M, Chien J, Cramer DW, et al. Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474:609-615. 10.1038/nature10166, 3163504, 21720365.
12. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005, 102:15545-50. 10.1073/pnas.0506580102, 1239896, 16199517.
13. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57. 10.1038/nprot.2008.211, 19131956.
14. Henrichsen CN, Vinckenbosch N, Zöllner S, Chaignat E, Pradervand S, et al. Segmental copy number variation shapes tissue transcriptomes. Nat Genet 2009, 41:424-9. 10.1038/ng.345, 19270705.
15. Chaignat E, Yahya-Graison EA, Henrichsen CN, Chrast J, Schütz F, et al. Copy number variation modifies expression time courses. Genome Res 2011, 21:106-13. 10.1101/gr.112748.110, 3012917, 21084671.
16. Wang E, Ngalame Y, Panelli MC, Nguyen-Jackson H, Deavers M, et al Peritoneal and Subperitoneal Stroma May Facilitate Regional Spread of Ovarian Cancer. Clin Cancer Res 2005, 11:113-122. Wang E, Ngalame Y, Panelli MC, Nguyen-Jackson H, Deavers M, et al.
17. Arnold JM, Huggard PR, Cummings M, Ramm GA, Chenevix-Trench G. Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma. Br J Cancer 2005, 92:2024-31. 10.1038/sj.bjc.6602596, 2361786, 15900302.
18. Yachida S, Jones S, Bozic I, Antal T, Leary R, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010, 467:1114-7. 10.1038/nature09515, 3148940, 20981102.
19. Gomez-Roca C, Raynaud CM, Penault-Llorca F, Mercier O, Commo F, et al. Differential expression of biomarkers in primary non-small cell lung cancer and metastatic sites. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009, 4:1212-20.